Literature DB >> 12397604

Role of endogenous regucalcin in nuclear regulation of regenerating rat liver: suppression of the enhanced ribonucleic acid synthesis activity.

Yoshinori Tsurusaki1, Masayoshi Yamaguchi.   

Abstract

The role of endogenous regucalcin in the regulation of ribonucleic acid (RNA) synthesis activity in the nucleus of normal and regenerating rat livers was investigated. Nuclear RNA synthesis was measured by the incorporation of [(3)H]-uridine 5'-triphosphate into the nuclear RNA in vitro. The presence of regucalcin (0.25 or 0.5 microM) in the reaction mixture caused a significant decrease in nuclear RNA synthesis of normal rat liver. alpha-Amanitin (10(-8)-10(-6) M), an inhibitor of RNA polymerase II and III, decreased significantly nuclear RNA synthesis activity. The effect of regucalcin (0.25 microM) in decreasing nuclear RNA synthesis activity was not seen in the presence of alpha-amanitin (10(-6) M). The calcium chloride (10 microM)-increased nuclear RNA synthesis activity was significantly suppressed by the addition of regucalcin (0.25 microM). RNA synthesis activity was significantly enhanced in the nuclei of regenating rat liver obtained at 24, 48, or 72 h after partial hepatectomy. This enhancement was significantly inhibited in the presence of PD98059 (10(-5) M), staurosporine (10(-6) M), or vanadate (10(-3) M). Western analysis of the nuclei of regenerating liver obtained at 24, 48, or 72 h after partial hepatectomy showed a significant increase in regucalcin protein as compared with that of sham-operated rats. The presence of anti-regucalcin monoclonal antibody (25 or 50 ng/ml) in the reaction mixture caused a significant increase in nuclear RNA synthesis activity of normal rat liver. This increase was completely blocked by the addition of regucalcin (1.0 microM). The effect of anti-regucalcin monoclonal antibody (50 ng/ml) in increasing nuclear RNA synthesis activity was significantly enhanced in the nuclei of regenerating liver obtained at 24, 48, or 72 h after partial hepatectomy. This enhancement was significantly suppressed by the addition of alpha-amanitin (10(-6) M), PD98059 (10(-5) M), staurosporine (10(-6) M), or vanadate (10(-3) M) in the reaction mixture. The present study demonstrates that endogenous regucalcin has a suppressive effect on the enhancement of RNA synthesis activity in the nucleus of regenerating rat liver with proliferative cells. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397604     DOI: 10.1002/jcb.10325

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Conjugated linoleic acid isomers modulate protein expression profile in rat hepatocytes.

Authors:  E Rossi; L Della Casa; S Piana; A Iannone
Journal:  Genes Nutr       Date:  2012-05-05       Impact factor: 5.523

Review 2.  Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy.

Authors:  Masayoshi Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-18       Impact factor: 4.553

Review 3.  Regucalcin and cell regulation: role as a suppressor protein in signal transduction.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2011-03-24       Impact factor: 3.396

4.  Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17beta-estradiol.

Authors:  Claudio J B Maia; Cecilia R Santos; Fernando Schmitt; Sílvia Socorro
Journal:  Mol Cell Biochem       Date:  2007-12-23       Impact factor: 3.396

5.  Liver gene expression profiles of rats treated with clofibric acid: comparison of whole liver and laser capture microdissected liver.

Authors:  Cécile Michel; Chantal Desdouets; Béatrice Sacre-Salem; Jean-Charles Gautier; Ruth Roberts; Eric Boitier
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 6.  Suppressive role of regucalcin in liver cell proliferation: involvement in carcinogenesis.

Authors:  M Yamaguchi
Journal:  Cell Prolif       Date:  2013-06       Impact factor: 6.831

7.  Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay.

Authors:  Sa Lv; Jiang-hua Wang; Feng Liu; Yan Gao; Ran Fei; Shao-cai Du; Lai Wei
Journal:  BMC Gastroenterol       Date:  2008-05-28       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.